A revolutionary new approach that analyzes a tiny sample of blood, can detect life-threatening vascular complications in diabetic patients earlier and more accurately than traditional tests.
The first prostate cancer treatment based on the genetic makeup of the cancer resulted in significant improvements, according to a large international trial led by Northwestern Medicine investigators.
A new study provided evidence that current guidelines for genetic screenings for colorectal cancer-associated genes are missing patients and should be expanded.
Many hospital rating systems are inconsistent and suffer from fundamental weaknesses, according to experts, as reported by a new Northwestern Medicine study.
Total deaths from heart disease, stroke, diabetes and hypertension have been increasing since 2011, according to a new Northwestern Medicine study.
The safety of a new therapy for an aggressive brain tumor was demonstrated in a recent clinical trial, and the drug also cleared other important hurdles.
A new blood test can identify early-stage liver cancer, allowing clinicians to start treatment early, according to a new study.
Northwestern Medicine scientists have developed and validated a tool to predict which patients with pre-osteoarthritis are at high risk for developing disability in the future.
A new study published in JAMA found neladenoson bialanate did not improve exercise capacity among patients suffering from heart failure with preserved ejection fraction.
A drug called tanezumab reduced pain and improved physical function in patients with osteoarthritis, although more research on safety is needed, according to a study published in JAMA.
Notifications